Development of Cagrilintide, a Long-Acting Amylin Analogue US$ 28.84 Min. order: 1 piece ★★★★★ 4.7 (143 reviews) Sold : Login>>
Novo Nordisk's next-gen obesity drug CagriSema trial results disappoint investors US$ 24.50 Min. order: 1 piece ★★★★★ 4.7 (171 reviews) Sold : Login>>
Novo Nordisk: Can CagriSema Show 25% Weight Loss In REDEFINE-1 Trial? US$ 23.18 Min. order: 1 piece ★★★★★ 4.2 (98 reviews) Sold : Login>>
New semaglutide and cagrilintide/semaglutide results US$ 23.95 Min. order: 1 piece ★★★★★ 4.8 (88 reviews) Sold : Login>>
Novo Nordisk Stock Rises on Trial Results for Cagrilintide Obesity Treatment US$ 22.44 Min. order: 1 piece ★★★★★ 5.0 (64 reviews) Sold : Login>>